Back to Search Start Over

[Sarcoidosis].

Authors :
Frye BC
Schupp JC
Köhler TC
Voll RE
Müller-Quernheim J
Source :
Zeitschrift fur Rheumatologie [Z Rheumatol] 2016 May; Vol. 75 (4), pp. 389-401.
Publication Year :
2016

Abstract

Sarcoidosis is a rare granulomatous disease mainly affecting lymph nodes and the lungs but joints, bones, muscles and other organs can also be affected. Sarcoidosis therefore represents an important differential diagnosis to various rheumatic diseases. For the diagnosis and differential diagnostic clarification, bronchoscopy including endobronchial ultrasound-guided fine needle aspiration of mediastinal and hilar lymph nodes represent the main procedures. Because of the high spontaneous remission rate initiating a therapy requires a therapeutic goal defined by sarcoidosis-associated functional organ impairment, especially for acute sarcoidosis. Cortisone represents the most commonly administered medication whereas methotrexate and azathioprine are well-established second-line medications. Antibodies which neutralize tumor necrosis factors (TNF) are a potential third-line therapy.

Details

Language :
German
ISSN :
1435-1250
Volume :
75
Issue :
4
Database :
MEDLINE
Journal :
Zeitschrift fur Rheumatologie
Publication Type :
Academic Journal
Accession number :
27146405
Full Text :
https://doi.org/10.1007/s00393-016-0086-2